RI-MUHC trainee wins award at Canadian Society of Nephrology meeting

Live 2021

Tho-Alfakar Al-Aubodah is a doctoral student in the Metabolic Disorders and Complications and Infectious Diseases and Immunity in Global Health Programs at the Research Institute of the MUHC

Source: RI-MUHC

The RI-MUHC congratulates Tho-Alfakar Al-Aubodah on his prize-winning abstract presentation at the 2021 Canadian Society of Nephrology Virtual AGM Meeting.

A doctoral student in the Metabolic Disorders and Complications Program and the Infectious Diseases and Immunity in Global Health Program at the RI-MUHC, Tho‑Alfakar Al-Aubodah is co-supervised by Drs. Tomoko Takano and Ciriaco Piccirillo. He received the second-place award for his abstract titled “B Cells and regulatory T Cells are differentially targeted by distinct immunosuppressive treatment strategies in pediatric idiopathic nephrotic syndrome.”

Idiopathic nephrotic syndrome is the most common chronic kidney disease among children, but its cause is not known despite five decades of research. This work aimed at pinning down the culprit immune cells that cause the disease. The discovery will help tailor the most effective treatment that will spare the affected children the heavy burden of side effects of currently used immune-suppressive drugs.

Congratulations Tho!

June 22, 2021

Be Sociable, Share!

Comments are closed.